Life Science Reagents

Miltenyi Biotec provides research- and clinical-grade products for sample preparation, cell separation, flow cytometry, and cell culture. Miltenyi Bioindustry, its CDMO division, offers services for developing and manufacturing cell and gene therapies, including lentiviral vectors, from preclinical to commercial scale. The company supports immunotherapy, regenerative medicine, and graft engineering with automated systems like CliniMACS Prodigy.

NanoTemper Technologies provides high-quality biophysical characterization instruments for life sciences and pharma research, including Prometheus for stability analysis, Dianthus for affinity screening, and Monolith for molecular interactions. These tools support biologics formulation, developability assessments, protein expression optimization, and challenging targets like membrane proteins and IDPs. Solutions feature technologies such as nanoDSF, DLS, Spectral Shift, MST, and NSM for precise, automation-ready workflows.

NanoTemper Technologies provides high-precision biophysical characterization tools for biopharma discovery, development, and manufacturing, including instruments like Dianthus, Prometheus Panta C, and Andromeda X. These enable protein stability assessment, binding analysis, expression screening, and label-free single-molecule analysis via recent acquisitions and launches. Solutions support end-to-end workflows from early drug discovery to commercial production, with features for 21 CFR Part 11 compliance and low sample volumes.

NEOsphere Biotechnologies provides a proteomics-based platform for targeted protein degradation (TPD) drug discovery, enabling high-throughput characterization and optimization of degrader compounds. Their technology offers proteome-wide screening, precise quantification, and rapid turnaround to identify novel targets and advance programs. Based in Munich, Germany, they partner with pharma companies like Kymera Therapeutics to accelerate TPD development.

Nicoya Lifesciences provides integrated biophysical characterization instruments for biopharma R&D, including Surface Plasmon Resonance (SPR) for label-free interaction analysis, Circular Dichroism (CD) for protein structure, stopped-flow kinetics, and differential scanning fluorimetry (DSF) for stability assessment. Following its 2025 acquisition of Applied Photophysics, Nicoya offers a unified platform combining these technologies to support drug discovery, optimization, and quality control workflows. Their benchtop systems like Alto, Revo, and Chirascan enable high-throughput, reproducible data for biologics developability and mechanism of action studies.

Nona Biosciences provides integrated antibody discovery, engineering, and development services using proprietary fully human transgenic mice platforms like Harbour Mice and HCAbs. Capabilities include bispecific/multispecific engineering, mRNA-LNP delivery, phage/yeast display, and AI-enhanced platforms such as Hu-mAtrIx for optimized lead selection. The company supports projects from antigen preparation through IND-enabling studies and early clinical development.

Glen Research, part of Maravai LifeSciences, provides reagents including phosphoramidites and solid supports for the chemical synthesis, modification, labeling, and purification of DNA and RNA oligonucleotides. Their Sterling™ line ensures high purity and performance for reliable results in life science research. The company supports applications such as aptamer development, fluorescent probe design, DNA crosslinking, and damage/repair studies.

Olink provides multiplexed proteomics solutions using Proximity Extension Assay (PEA) technology for high-throughput analysis of up to 5,400 proteins with high specificity and sensitivity. They offer targeted and explore panels focused on areas like inflammation, oncology, cardiometabolic, and neurology, available as kits for labs or through certified analysis services. These tools support biomarker discovery and research in pharma and life sciences with small sample volumes and scalable quantification.

Olink, part of Thermo Fisher Scientific, offers multiplexed proteomics panels measuring up to 5,400 proteins with high specificity for biomarker discovery and analysis in life sciences and pharma research. They provide Olink Analysis Services through certified labs in Uppsala and Boston, handling pre-study consultation to data delivery, or kits for in-house use. A global network of certified service providers, including CROs, enables scalable, high-throughput protein profiling with low sample volumes.

PhoreMost is a UK-based biopharmaceutical company specializing in targeted protein degradation (TPD) through its proprietary SITESEEKER and GlueSEEKER platforms. These technologies enable phenotypic screening to identify novel druggable targets across the proteome and develop molecular glue degraders for oncology and inflammation. The company collaborates with partners like Arvinas to advance degrader therapeutics.

Phylloceuticals develops plant-based bioprocessing technology (PhAAST™) using genetically modified tobacco (Nicotiana sp.) and Lemna sp. to produce therapeutic proteins, vaccine antigens, and antibodies faster and cheaper than traditional mammalian cell methods. The automated hydroponic and aquaculture systems enable rapid scaling, such as 50 million vaccine doses in 12 weeks, with no animal-derived products or human contact required. They focus on biosimilars, novel drugs, animal health, and clinical trial materials as a supplier to commercialization entities.

Alamar Biosciences is a proteomics company providing ultra-sensitive protein biomarker detection platforms for early disease detection and precision health research. The company's NULISA technology and ARGO HT system enable attomolar-level sensitivity with up to 12-log dynamic range for multiplexed protein analysis from liquid biopsies. Their applications span early-stage discovery, translational research, and clinical diagnostics, with particular focus on neurological and inflammatory biomarker detection.

ProImmune provides specialized reagents and services for T-cell immunology research, including ProVE SL Self-Loading MHC Class I Monomers for flexible antigen-specific CD8+ T-cell detection across over 50 HLA alleles. They offer REVEAL for rapid epitope discovery and collaborate on tools like Ankyrons for high-containment infectious disease studies. These products support pharmaceutical R&D in vaccine development, immunotherapy, and immune monitoring.

Promega offers over 4,000 products including reagents, kits, and instruments for cell biology, nucleic acid analysis, protein research, drug discovery, human identification, and molecular diagnostics. The company provides solutions for biologics drug discovery, custom assay development, and manufacturing services to support pharma R&D and production. Global technical support and custom workflows accelerate customer projects in life sciences.

RedShiftBio provides analytical instrumentation using Microfluidic Modulation Spectroscopy (MMS) and Liquid Chromatography (HaLCon) for protein and RNA analysis in drug development. Their Aurora TX and AQS3pro systems enable ultra-sensitive measurements of biomolecule structure, stability, aggregation, and concentration across wide ranges without dilution. These tools support bioprocessing, formulation, and characterization for therapeutic modalities including proteins and RNA.

Protein Dynamic Solutions offers the ProteinMentor® platform, a high-throughput hyperspectral imaging tool using quantum cascade laser microscopy for critical quality attribute (CQA) analysis in biopharmaceuticals. It enables rapid assessment of protein stability, aggregation, deamidation, and developability, supporting candidate selection, formulation optimization, and release testing. The platform reduces analysis times by over 200x compared to traditional methods, accelerating time to market while lowering costs and enhancing regulatory compliance.

Protein Metrics provides vendor-neutral mass spectrometry software for comprehensive protein and oligonucleotide analysis throughout biopharmaceutical development. The platform offers instrument-agnostic solutions trusted by over 200 biopharmaceutical companies and 300 academic institutions for protein characterization, quantification, and reporting. Their Byos desktop and Byosphere cloud-based platforms enable rapid analysis of complex protein mixtures, host cell protein detection, and multi-protein quantitation workflows processing gigabytes of data.

ProteomEdge develops multiplex panels of isotope-labeled protein standards for absolute protein quantification using mass spectrometry. Their products support biomarker research and translational applications in blood-based proteomics for pharma and life sciences. The company offers DiscoveryEdge 600 and plans additional targeted panels and expanded discovery products in early 2026.

PreOmics provides innovative sample preparation kits like iST and ENRICH-iST for LC-MS proteomics analysis, enabling robust processing of peptides and proteins in 2 hours. These solutions support manual, semi-automated, or fully automated workflows on platforms like PreON and Hamilton STAR V, enhancing throughput and reproducibility. They address dynamic range challenges in plasma and serum proteomics, increasing protein detection depth by 50-100%.

Biognosys provides next-generation proteomics solutions for pharmaceutical R&D and life sciences organizations, specializing in mass spectrometry-based protein analysis, proteogenomics, and biomarker discovery. Their platform enables comprehensive protein expression profiling, post-translational modification analysis, and quantitative proteome characterization to support drug development, target validation, and personalized medicine applications.

ProteoNic Biosciences provides premium vector and transposon technology, including the 2G UNic® platform, to boost protein production in mammalian, yeast, and fungal cells for biopharmaceutical manufacturing. Their solutions enhance expression of complex proteins like multi-specific antibodies, fusion proteins, and viral vectors, improving productivity and titers. The company supports biologics R&D and production, with recent licensing of 2G UNic® to Ginkgo Bioworks for BARDA-funded anti-filovirus therapies.

Quantabio provides advanced DNA and RNA amplification reagents for PCR, qPCR, RT-PCR, and NGS applications in life sciences and pharmaceutical research. Their proprietary ToughMix and qScript technologies deliver robust performance against PCR inhibitors, supporting pathogen detection, infectious disease assays, and library preparation for Illumina platforms. Products like UltraPlex 1-Step ToughMix enhance CDC protocols for respiratory disease detection, including COVID-19 and influenza.

Abselion develops the Amperia benchtop platform using proprietary Redox Electrochemical Detection (RED) technology for fast, accurate quantification of proteins, antibodies, and viral vectors without optics or fluidics. The system simplifies workflows in life sciences, biotech, and therapeutic development with ready-to-use kits like Protein G for broad IgG subclass and species titre measurement. Based in Cambridge, UK, with a new US subsidiary, it supports research, process development, and bioprocessing for reliable data from complex samples.

Rockland Immunochemicals specializes in high-quality antibodies, reagents, and custom services for life sciences and pharmaceutical research. As a CRO and CMO, they offer GLP-compliant antibody development, assay design, bioprocessing solutions, and critical reagents for academic, biopharma, and diagnostic applications. Their Pennsylvania-based facilities support end-to-end solutions from proof-of-concept to CGMP tech transfer across modalities like monoclonal antibodies and cell/gene therapies.